Eleven newly named researchers will be the first group to embark on President Joe Biden's Cancer Moonshot, sharing $5.4 million in scholarships to "fight to end cancer as we know it," according to an Aug. 3 White House news release.

Cost-Saving Robotic Tech Bringing World-Class Care to >90% of Cancer Patients Who Currently Lack Access

Detroit-based Barbara Ann Karmanos Cancer Institute, a McLaren Health Care-owned facility, has named Boris Pasche, MD, PhD, as the center's new president and CEO, according to an Aug. 7 news release.

Three more cancer drugs are in short supply, according to the FDA and the American Society of Health-System Pharmacists.

Here are stories covering recent research, treatment, strategy and moves from some of the nation's top cancer hospitals:

While still in contract negotiations, registered nurses at Dana-Farber Cancer Institute - Merrimack Valley in Methuen, Mass., voted 33 to 1 to authorize a one-day strike, the Massachusetts Nurses Association said in an NBC Boston report. 

Researchers at Los Angeles-based City of Hope recently announced promising results for a new chemotherapy pill that "appears to annihilate all solid tumors," according to research published Aug. 1 in Cell Chemical Biology. 

The FDA approved GSK's Jemperli (dostarlimab) in combination with carboplatin and paclitaxel for adults with primary advanced or recurrent endometrial cancer who are mismatch repair deficient or microsatellite instability-high.

The University of Texas MD Anderson Cancer Center in Houston earned the No. 1 spot on U.S. News & World Report's "2023-24 Best Hospitals for Cancer" rankings, released Aug. 1. 

Eleven major cancer centers, or health systems with notable ones, have made Forbes' 2023 list of best places to work in the U.S. for women. 

Injectable versions of some widely used cancer drugs may be excluded from the new Medicare price negotiations until the 2030s, Reuters reported July 28.

Cancer care pioneer Irwin Krakoff, MD, celebrated his 100th birthday July 20. 

Cancer treatment is more than its therapies, and hospitals are utilizing a number of medical practices, social determinants of health programs and technologies to make cancer care more accessible and effective.

Cancer's aggressive tendency to spread, grow and further deteriorate the bodies that house it, may be reversible making it become its own aggressor, attacking and destroying itself, according to research published July 26 in Nature. 

Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., is seeking out a public relations firm to help boost its diversity, equity and inclusion presence and efforts after previously refusing to release a DEI report and being accused of racism, according to Buffalo News.

Almost 80 percent of pancreatic cancer patients in Texas are not getting the level of standard-of-care surgery that could prolong survival, according to a study published May 23 in the Journal of Surgical Oncology.

A $400 million inpatient surgical hospital will open July 31 at the Moffitt Cancer Center in Tampa, Fla., according to a July 21 WUSF news release.

Here are nine cancer studies and research you might have missed:

Oncology leaders face many challenges in the field, and three in particular are top of mind: timeliness, treatment options and innovations.

Many agencies are delaying cancer trials and research due to cancer drug shortages, which may have a long-term effect on treatments, CNN reported July 20.